Blog | HemaCare

Tumor Cell–Loaded Dendritic Cells Improve Adoptive T-Cell Therapy

Dec 19, 2016 12:00:00 AM / by Stacy Matthews Branch, DVM, PhD posted in prostate cancer treatment, dendritic cell vaccine, Dendritic cells, prostate cancer, research

0 Comments

Tumor-specific cytotoxic T cells are used in patients with cancer with the goal of providing specific recognition and destruction of tumor cells. In adoptive T cell therapy, tumor-specific T cells are collected and multiplied (expanded) outside the body. This is done to obtain a much larger number of the tumor-specific T cells that the patient can be treated with more successfully.

Read More

Prostate Cancer Prognosis through PBMC Sampling

Apr 20, 2015 1:00:12 PM / by Daisy posted in circulating tumor cell, CTC, prostate cancer, research, telomerase

0 Comments

Technology exists for isolating rare circulating tumor cells (CTC) that bud off solid tumors into the PBMC fraction of blood. What can we learn from CTCs?

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts